Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Dianette (Cyproterone Acetate 2mg/Ethinylestradiol 35mcg) - NEW RISK MINIMISATION MEASURES TO FURTHER MITIGATE THE KNOWN RISK OF THROMBOEMBOLISM
Notice type:
3rd Party Publications
Date:
01/07/2013
Product name or type:
Dianette (Cyproterone Acetate 2mg/Ethinylestradiol 35mcg) - NEW RISK MINIMISATION MEASURES TO FURTHER MITIGATE THE KNOWN RISK OF THROMBOEMBOLISM
Reference:
MIMS Publication - July 2013
Background Information Or Related Documents:
Dianette (Cyproterone Acetate 2mg/Ethinylestradiol 35mcg) - NEW RISK MINIMISATION MEASURES TO FURTHER MITIGATE THE KNOWN RISK OF THROMBOEMBOLISM Document
Further Information:
Dianette (Cyproterone Acetate 2mg/Ethinylestradiol 25mcg) - NEW RISK MINIMISATION MEASURES TO FURTHER MITIGATE THE KNOWN RISK OF THROMBOEMBOLISM
- MIMS Publication July 2013
« Back
Date Printed: 19/05/2024